Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

834.04
+7.400.90%
Post-market: 834.040.00000.00%19:58 EDT
Volume:786.92K
Turnover:656.91M
Market Cap:85.87B
PE:20.63
High:847.00
Open:835.74
Low:826.64
Close:826.64
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:1.27
T/O Rate:0.80%
Dividend:3.64
Dividend Rate:0.44%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.71
PE(LYR):20.11

Loading ...

Regeneron Pharmaceuticals - Expects Q2 2026 Bought Ipr&d Charge of $127 Mln Pre-tax - SEC Filing

THOMSON REUTERS
·
Jul 06

Regeneron Pharmaceuticals - Expects Q2 2026 Gaap and Non-gaap Net Income Per Diluted Share to Decrease by $1 - SEC Filing

THOMSON REUTERS
·
Jul 06

Regeneron Pharmaceuticals Inc Q2 Shr View $10.81

THOMSON REUTERS
·
Jul 06

U.S. Research Roundup-east West Bancorp, First Citizens Bancshares, UMB Financial

Reuters
·
Jul 06

Eli Lilly, Regeneron Among First Companies Selected for FDA Initiative to Speed Review of New Manufacturing Facilities - CNBC

Reuters
·
Jul 06

Regeneron Pharmaceuticals Inc : HSBC Cuts Target Price to $800 from $990

THOMSON REUTERS
·
Jul 06

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 03

Movement Alert|Regeneron Pharmaceuticals Rises 3.1% in Regular Trading, Selected for FDA Production Pilot Plus Priority Review for Novel Drug

Market Focus
·
Jul 02

Analysts Conflicted on These Healthcare Names: Alumis Inc. (ALMS), Glaukos (GKOS) and Regeneron (REGN)

TIPRANKS
·
Jul 01

Regeneron Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 01

US FDA - Amneal, Cellares, Eli Lilly, Fujifilm, Kriya, Kyowa Kirin, Regeneron Join FDA Precheck Pilot

THOMSON REUTERS
·
Jun 30

Market Chatter: Eli Lilly, Regeneron Among First Companies in FDA PreCheck Pilot Program

MT Newswires Live
·
Jun 30

Lilly, Regeneron Selected for US Program to Review New Manufacturing Plants Faster

Reuters
·
Jun 30

Eli Lilly, Regeneron among first selections for FDA PreCheck program, CNBC says

TIPRANKS
·
Jun 30

Eli Lilly, Regeneron Among First Companies Selected for FDA Initiative to Speed Review of New Manufacturing Facilities - CNBC

THOMSON REUTERS
·
Jun 30

Healthcare Stocks Have Become a Haven for Investors Ditching Tech

Dow Jones
·
Jun 27

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 27

How Investors May Respond To Regeneron Pharmaceuticals (REGN) Cemdisiran Priority Review for gMG Treatment

Simply Wall St.
·
Jun 27

Regeneron Updates Financial Calendar for Second-quarter Results Release and Conference Call

Reuters
·
Jun 26

Regeneron’s New First-in-Human Eczema Drug REGN20423: Early Trial Progress and Investor Takeaways

TIPRANKS
·
Jun 26